ホーム › 急性骨髄性白血病 › ニューヨーク › The Bronx
The Bronx、NYにおける急性骨髄性白血病の臨床試験
The Bronxとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Montefiore Medical Center - Moses Campus, The Bronx
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
被験者募集中第2/3相
- Montefiore Medical Center - Moses Campus /ID# 279399, The Bronx
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Montefiore Medical Center - Moses Campus, The Bronx
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
被験者募集中第3相
- Einstein-Montefiore Medical Center, The Bronx
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Montefiore Medical Center - Moses Campus, The Bronx
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- Montefiore Medical Center - Moses Campus, The Bronx
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
被験者募集中第3相
- Montefiore Medical Center - Moses Campus, The Bronx
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Montefiore Medical Center - Moses Campus, The Bronx
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's Hospital at Montefiore, The Bronx
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
被験者募集中第1相
- Montefiore Medical Center, The Bronx
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
被験者募集中第2/3相
- Montefiore Medical Center, The Bronx
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
被験者募集中第1相
- Montefiore Medical Center, The Bronx
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
被験者募集中第1相
- Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
被験者募集中第2相
- Montefiore Medical Center, The Bronx
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
被験者募集中第1相健康なボランティア歓迎
- Montefiore Medical Center, The Bronx
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Baldwin Park, CA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
The Bronxにおける他の研究
- 非小細胞肺癌25件の研究
- 乳がん17件の研究
- 肺がん13件の研究
- がん（全種類）12件の研究
- 心血管疾患12件の研究
- 心不全11件の研究
- 前立腺がん11件の研究
- 転移性癌9件の研究
- 大腸癌9件の研究
- 頭頸部扁平上皮癌9件の研究
- 骨髄異形成症候群9件の研究
- 喘息9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。